Apigee Launches Monetization Services to Maximize Value

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Apigee Launches Monetization Services to Maximize Value From Digital Initiatives

PALO ALTO, CA--(Marketwired - Jul 18, 2013) - Apigee , the API company, today launched Apigee Enterprise - Monetization Services , a major new offering that makes it easy for customers to maximize the business value and foster rapid growth of their API-based digital initiatives. Fully integrated with the Apigee Enterprise API platform, Apigee Monetization Services delivers enterprise-grade API monetization functionality to support a wide range of business models. This new flexible capability is designed specifically for dynamic digital initiatives built on apps, data and APIs.

"The API and developer programs at the heart of mobile strategies are increasingly business critical and provide opportunities to create new revenue streams. Existing financial management solutions are simply not designed to take advantage of new transactional opportunities enabled by apps and APIs," said Chet Kapoor, Apigee CEO. "Apigee Monetization Services is not just about pricing digital assets, but also understanding what to price, monitoring plan performance, and easily adapting to meet optimal monetization terms. It's the only fully integrated, end-to-end solution for managing the entire monetization process, from purchase to payment."

End-to-End API Monetization for Business Users

Apigee Monetization Services empowers non-technical business users to manage the complete, end-to-end process of monetizing digital assets -- including creating rate plans, managing limits and notifications, configuring reports and billing documents, and modifying the system to maximize API program value. It offers an extensive degree of flexibility to create customized plans or use the "out-of-the-box" plans that cover all revenue models, including fixed and variable fees, revenue sharing, and even "freemium" plans.

Apigee Monetization Services is integrated with Apigee Enterprise , a complete platform for creating, managing and measuring digital initiatives built on apps, data and APIs. Through this unique integration, the entire monetization process -- including all communication between providers and developers -- is automated. For example:

  • Rate plans and changes to plans created in Apigee Monetization Services are automatically published to the developer portal for immediate use by the developer community
  • Rate plan limits and notifications set in Apigee Monetization Services are automatically reflected in real time in the Apigee Enterprise platform
  • The API provider is automatically notified when a developer purchases or changes their plan or is reaching plan limits
  • Performance of developers, packages and plans are constantly monitored in Apigee, enabling API providers the agility to react and adjust plans in real time -- testing and refining across a range of scenarios and variables

Apigee Monetization Services can also be easily integrated with any existing accounting, ERP, sales or other backend system to provide consistency and coordination with established business processes.

"It's critical that businesses have the freedom to explore all the ways to orchestrate value creation through APIs. Our monetization capabilities provide the flexibility and agility to allow API providers to quickly determine and execute on the right business strategy for their digital initiatives," added Kapoor.

Availability

Apigee Monetization Services is sold as an add-on to Apigee Enterprise, available either in the cloud or on premises. It will be widely available in August, 2013. For more information about Apigee Monetization Services, please go to http://apigee.com/about/enterprise#products-monetization or email info@apigee.com .

About Apigee

Apigee empowers enterprises and developers to succeed in a dynamic, connected mobile world. Apigee's flagship offering is Apigee Enterprise , a platform that helps customers transform and innovate with apps, data and APIs. Hundreds of companies including Walgreens, Bechtel, eBay, Pearson, and Gilt Groupe and over a hundred thousand developers use Apigee to securely deliver APIs, drive developer adoption, quickly build powerful apps, and analyze the massive amount of data generated in the digital economy. Apigee's global headquarters are in Palo Alto, California, and it has offices in Bangalore, India, London, Austin and Detroit. To learn more, go to www.apigee.com .

Apigee is a registered trademark in the U.S. Other product or company names mentioned may be trademarks or trade names of their respective companies.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 387

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 544

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 109

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 305

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 161

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 411

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 174

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 277

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Breakthroughs in Lung Cancer Treatment with Reqorsa

Updated Category News Views 182

Innovative Advances in Lung Cancer Treatment The fight against lung cancer continues to evolve, showcasing promising advancements that bring new hope to patients. Genprex, Inc. is at the forefront of this battle with its revolutionary gene therapy known as Reqorsa. This cutting-edge treatment has been developed specifically to target KRAS mutation in non-small cell lung...

Continue Reading
EfTEN United Property Fund Reports October Earnings and NAV

Updated Category News Views 192

Insights into EfTEN United Property Fund's Recent Performance EfTEN United Property Fund demonstrated a net profit of 110 thousand euros for October, totaling 2.214 million euros for the first ten months of the year, marking a significant improvement from 724 thousand euros during the same period last year. This impressive financial outcome led to a distribution to...

Continue Reading
Cardiff Oncology Reports Encouraging Results in mCRC Trial

Updated Category News Views 236

Cardiff Oncology Reveals Promising Clinical Trial Results Cardiff Oncology, Inc. (Nasdaq: CRDF), a pioneering clinical-stage biotechnology company, has recently announced encouraging results from its ongoing CRDF-004 clinical trial. This randomized Phase 2 trial is investigating the effects of onvansertib in patients suffering from first-line RAS-mutated metastatic...

Continue Reading
Japan's Growing Casting Polyurethane Market and Its Future

Updated Category News Views 127

Japan's Casting Polyurethane Market: A Rising Force The Japan casting polyurethane market is on the verge of significant transformation, anticipated to elevate from a valuation of US$ 134.74 million to a remarkable US$ 248.24 million by 2033. This growth trajectory highlights a compelling compound annual growth rate (CAGR) of 7.08%, revealing the underlying strength...

Continue Reading
Hudson Technologies Faces Challenges Amid Downgrade by B.Riley

Updated Category News Views 353

B.Riley Downgrades Hudson Technologies Stock In a recent market statement, B.Riley has lowered its outlook on Hudson Technologies (NASDAQ: HDSN), shifting the stock rating from Buy to Neutral. This adjustment comes amidst new growth projections adjusted downwards from +16.6% to +8.5%. The modification in expectations has been linked to ongoing pressures on...

Continue Reading